269 related articles for article (PubMed ID: 28030567)
21. Suppressor of Fused restraint of Hedgehog activity level is critical for osteogenic proliferation and differentiation during calvarial bone development.
Li J; Cui Y; Xu J; Wang Q; Yang X; Li Y; Zhang X; Qiu M; Zhang Z; Zhang Z
J Biol Chem; 2017 Sep; 292(38):15814-15825. PubMed ID: 28794157
[TBL] [Abstract][Full Text] [Related]
22. The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
Tusa I; Gagliardi S; Tubita A; Pandolfi S; Menconi A; Lulli M; Dello Sbarba P; Stecca B; Rovida E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681917
[TBL] [Abstract][Full Text] [Related]
23. MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.
Lu J; Liu L; Zheng M; Li X; Wu A; Wu Q; Liao C; Zou J; Song H
Oncogene; 2018 Jul; 37(28):3864-3878. PubMed ID: 29662197
[TBL] [Abstract][Full Text] [Related]
24. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
[TBL] [Abstract][Full Text] [Related]
25. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
[TBL] [Abstract][Full Text] [Related]
26. Novel mechanism of action on Hedgehog signaling by a suppressor of fused carboxy terminal variant.
Tostar U; Finta C; Rahman MF; Shimokawa T; Zaphiropoulos PG
PLoS One; 2012; 7(5):e37761. PubMed ID: 22666390
[TBL] [Abstract][Full Text] [Related]
27. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas.
Albert B; Hahn H
Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374
[TBL] [Abstract][Full Text] [Related]
28. Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma.
Li ZJ; Mack SC; Mak TH; Angers S; Taylor MD; Hui CC
Oncogene; 2014 May; 33(20):2674-80. PubMed ID: 23752195
[TBL] [Abstract][Full Text] [Related]
29. Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
Moutasim KA; Mellows T; Mellone M; Lopez MA; Tod J; Kiely PC; Sapienza K; Greco A; Neill GW; Violette S; Weinreb PH; Marshall JF; Ottensmeier CH; Sayan AE; Jenei V; Thomas GJ
J Pathol; 2014 Jun; 233(2):196-208. PubMed ID: 24573955
[TBL] [Abstract][Full Text] [Related]
30. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
Dheeraj A; Rigby CM; O'Bryant CL; Agarwal C; Singh RP; Deep G; Agarwal R
Photochem Photobiol; 2017 Jul; 93(4):999-1007. PubMed ID: 28120452
[TBL] [Abstract][Full Text] [Related]
31. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.
Regl G; Neill GW; Eichberger T; Kasper M; Ikram MS; Koller J; Hintner H; Quinn AG; Frischauf AM; Aberger F
Oncogene; 2002 Aug; 21(36):5529-39. PubMed ID: 12165851
[TBL] [Abstract][Full Text] [Related]
32. Basal cell carcinomas: attack of the hedgehog.
Epstein EH
Nat Rev Cancer; 2008 Oct; 8(10):743-54. PubMed ID: 18813320
[TBL] [Abstract][Full Text] [Related]
33. Understanding the Molecular Genetics of Basal Cell Carcinoma.
Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
[TBL] [Abstract][Full Text] [Related]
34. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
[TBL] [Abstract][Full Text] [Related]
35. Differential requirement of SUFU in tissue development discovered in a hypomorphic mouse model.
Hoelzl MA; Heby-Henricson K; Gerling M; Dias JM; Kuiper RV; Trünkle C; Bergström Å; Ericson J; Toftgård R; Teglund S
Dev Biol; 2017 Sep; 429(1):132-146. PubMed ID: 28688895
[TBL] [Abstract][Full Text] [Related]
36. [The role of sonic hedgehog pathway in skin carcinogenesis].
Lesiak A; Sysa-Jedrzejowska A; Narbutt J
Pol Merkur Lekarski; 2010 Aug; 29(170):141-3. PubMed ID: 20842831
[TBL] [Abstract][Full Text] [Related]
37. Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics.
Bisceglia M; Panniello G; Galliani CA; Centola M; D'Errico MM; Minenna E; Tucci FA; Ben-Dor DJ
Adv Anat Pathol; 2020 Sep; 27(5):331-353. PubMed ID: 32618586
[TBL] [Abstract][Full Text] [Related]
38. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma.
Lupi O
Int J Dermatol; 2007 Nov; 46(11):1113-7. PubMed ID: 17988327
[TBL] [Abstract][Full Text] [Related]
39. Basal cell carcinoma: pathophysiology.
Sehgal VN; Chatterjee K; Pandhi D; Khurana A
Skinmed; 2014; 12(3):176-81. PubMed ID: 25134314
[TBL] [Abstract][Full Text] [Related]
40. Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
Grund-Gröschke S; Ortner D; Szenes-Nagy AB; Zaborsky N; Weiss R; Neureiter D; Wipplinger M; Risch A; Hammerl P; Greil R; Sibilia M; Gratz IK; Stoitzner P; Aberger F
Mol Oncol; 2020 Sep; 14(9):1930-1946. PubMed ID: 32615027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
